CMAJ maps the path from submission to acceptance
The editorial process at CMAJ is built around staged review, repeated editorial scrutiny, and multiple opportunities for revision before a manuscript is accepted. For research and guideline articles, submission is only the first checkpoint. Two or more editors first assess the paper internally, and that review can lead to rejection, a request for pre-review revision, or referral to external peer review. The workflow is deliberately iterative rather than linear, which gives the journal room to filter out weak submissions early while preserving a path for manuscripts that need clarification rather than wholesale rejection.
A paper that survives the opening screen moves into external peer review by two or more reviewers. Their assessments can still end the process outright, but they can also push the manuscript toward discussion at a manuscript meeting. This structure reflects a familiar tension in scholarly medicine: peer review is meant to test scientific merit, yet it also works best when editors remain actively engaged rather than acting as passive receivers of reviewer comments.
A manuscript meeting adds another layer of judgment. Three or more editors discuss the submission and can reject it, accept it, ask for further peer review, or request revision. The result is a process that repeatedly narrows uncertainty. Each stage asks a different question: is the paper sound enough to proceed, is the evidence convincing, and is the manuscript ready to enter the permanent record in a form that will hold up under scrutiny?
Revision is not the end of review
Manuscripts that are revised do not re-enter the system on autopilot. A revised submission returns to internal review and, when necessary, to another manuscript meeting. From there, the decision may still be rejection, acceptance, or another round of revision. That looping design matters because it places editorial judgment at the center of the process instead of treating revision as a box-checking exercise. A paper can improve materially after review, but it still has to satisfy the journal’s standards for clarity, scientific rigor, and relevance.
The path is especially important for articles in medicine, where ambiguous methods, incomplete reporting, or overstated conclusions can distort clinical interpretation. A careful revision cycle can expose missing detail and force authors to sharpen claims before publication. In practice, this means the journal is not simply asking whether a paper can be published; it is deciding whether it should be published in a form that clinicians, researchers, and policymakers can trust.
Acceptance is also not the final endpoint in the editorial chain. Once a manuscript is accepted, a scientific manuscript editor revises the text for clarity, brevity, style, and accuracy. This stage can uncover additional gaps or points that need clarification. Authors then review the edited proof and answer every query. Before finalization, a senior editor performs one more review. The procedure is exacting because small errors in medical publishing can change interpretation, alter clinical emphasis, or weaken confidence in the final article.
A proof is not a formality. It is a final clinical document in the making.
Post-accept editing can still change the record
The post-accept stage shows how much editorial work continues after acceptance. Scientific manuscript editors are not just polishing prose; they are checking whether the manuscript says what the data actually support. That distinction is consequential in clinical publishing, where wording can influence how readers understand risk, benefit, and certainty. If a method is unclear or a result is presented too broadly, the editor can surface the problem before publication locks it in.
This process also places responsibility on the authors after acceptance. They must review the proof carefully and respond to all queries, and the journal asks them to identify a coauthor who can answer questions if the corresponding author is unavailable. In fast-moving clinical research, that logistical detail helps prevent delay at exactly the point where timely clarification may still be needed.
The final senior-editor review adds a last quality barrier. By the time a paper reaches that stage, the journal has already invested multiple rounds of editorial attention, but the final check still matters because the goal is not only accurate science but a reliable published record. Readers often assume publication means completion; the editorial workflow makes clear that completion comes only after the manuscript has survived a sequence of increasingly refined tests.
Fast-tracking depends on justification, not urgency alone
also describes a path for accelerated review or publication, but the bar is explicit. Authors seeking fast-tracking must contact the editor well before submission and justify in writing why the findings merit accelerated handling. High importance is one possible reason. A conference deadline is not, by itself, likely to persuade the journal.
That policy reflects a practical editorial principle: speed can serve medicine when the research is unusually consequential, but haste without a strong scientific rationale risks lowering standards. Journals that publish clinical research sit at a difficult intersection between timeliness and reliability. Too much delay can slow the movement of important evidence into practice. Too much acceleration can allow weak or incomplete work to reach clinicians before it has been properly tested.
Fast-tracking therefore operates as an exception, not a default service. It is reserved for findings that carry enough importance to justify priority handling, and even then the request must be made in advance and defended in writing. The threshold is intentionally high because accelerated publication changes the editorial workload and compresses the review timeline, both of which can strain the safeguards designed to protect the quality of the literature.
For authors, the message is clear: an urgent timeline is not enough. The manuscript must earn priority.
Why the workflow matters for clinical readers
For clinicians, the value of this process is not procedural trivia. It shapes the trustworthiness of what reaches bedside decision-making, guideline debates, and future research design. Each gate in the system is intended to catch different failures: poor framing at the editorial screen, methodologic weakness in peer review, interpretive problems at manuscript meetings, and residual errors during proofing. In medical publishing, quality is cumulative.
The journal’s structure also reveals how much invisible labor sits behind a polished paper. Internal editors, external reviewers, manuscript editors, senior editors, and authors all contribute to the final version. The end product may read seamlessly, but it has usually been tested against disagreement, revision, and reinspection. In a field where clinical claims can influence prescribing, diagnosis, and policy, that layered scrutiny is not administrative excess. It is the mechanism by which a manuscript becomes a dependable scientific report.